Comparison Chart Provectus Biopharmaceuticals, Inc.

Stocks

PVCT

US74373P1084

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 19:19:22 27/07/2026 +04			5-day change	1st Jan Change
0.0620 ^USD	-0.18%		+3.85%	+10.91%

07-07	Provectus Biopharmaceuticals, Inc. Highlights Peer-Reviewed Study Demonstrating Opposing Mechanistic Effects Of Rose Bengal Sodium At The Same Dose	CI
06-25	Provectus Biopharmaceuticals, Inc. Launches Veripure Open Science Program For Medical Research Access To PV-10	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PROVECTUS BIOPHARMACEUTICALS, INC.	Bio Therapeutic Drugs	-0.18%	+3.85%	+10.91%	-21.62%	-10.79%	26.1M	-	-	-